/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Ferric derisomaltose versus usual care in patients with heart failure, reduced ejection fraction, and iron deficiency: a short-term UK cost-utility analysis based on the IRONMAN RCT
Event: ESC Congress 2024
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Session: Collateral damage in heart failure: comorbidities and their treatment
